Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Insulin aspart

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 86,022Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    31/10/2025 Amphastar Pharmaceuticals
    U.S.A
    		 Amphastar Nanjing Pharmaceuticals, Inc. 52221-115 Insulin Aspart 2015-08-25 2025-12-31 BULK INGREDIENT POWDER (1kg/kg)
    31/10/2025 Hefei Xinzhu Biological Technology Co., Ltd. 85893-009 Insulin Aspart 2025-10-22 2026-12-31 BULK INGREDIENT POWDER (100g/100g)